Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complicat (Q37127488)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 October 2007
edit
Language Label Description Also known as
English
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complicat
scientific article published on 03 October 2007

    Statements

    Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complicat (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    Hussam Al-Kateb
    Andrew P Boright
    Lucia Mirea
    Xinlei Xie
    Rinku Sutradhar
    Alireza Mowjoodi
    Bhupinder Bharaj
    Michelle Liu
    Jean M Bucksa
    Valerie L Arends
    Michael W Steffes
    Patricia A Cleary
    Wanjie Sun
    Paul S Thorner
    Michael Ho
    David A Savage
    Judith R Kidd
    William C Speed
    Lei Sun
    Shelley B Bull
    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    3 October 2007
    218-228

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit